January 23, 2026
IAVI and Partners Announce the 8th Global Forum on TB Vaccines in April 2027 in Zaragoza, Spain
The 8th Global Forum will take place from April 12-14, 2027—marking a return to the European region and the first time in a Spanish-speaking country
IAVI, the Stop TB Partnership Working Group on New TB Vaccines (WGNV), the Tuberculosis Vaccine Initiative (TBVI), and the University of Zaragoza are pleased to announce that the 8th Global Forum on TB Vaccines will take place in Zaragoza, Spain, from 12 – 14 April 2027. This edition marks the return of the Global Forum to the European region—a hub for research and innovation in the field—and the first time this important convening on TB vaccine research, development, and implementation will be held in a Spanish-speaking country.
“The University of Zaragoza brings together scientific excellence, institutional commitment to vaccine development, and a rich culture and history as host of the upcoming 8th Global Forum on TB Vaccines,” said Rosa Bolea, Rector, University of Zaragoza, Spain. “We look forward to welcoming the global TB vaccine community to Zaragoza to share in the capacity of our university, region, and country as partners and leaders in vaccine research and to strengthen international alliances in the fight against tuberculosis.”
The Global Forum on TB Vaccines is convened every two to three years by the WGNV in collaboration with IAVI, TBVI, and a partner in the host country. The 8th Global Forum is expected to bring more than 400 stakeholders from over 35 countries and all sectors of tuberculosis vaccine research, development, and implementation to Zaragoza.
“IAVI, TBVI, and WGNV are thrilled that the 8th Global Forum on TB Vaccines will take place in Spain. With its world-renowned research institutions, diverse expertise, and commitment to global collaboration, Spain is an ideal venue for the next Global Forum,” said David Lewinsohn, Chair, WGNV; Mark Feinberg, President & CEO, IAVI; and Ole Olesen, Executive Director, TBVI, on behalf of the organizing partners. “During this pivotal moment for the field, the 8th Global Forum will bring together the global TB vaccine community in Zaragoza to reflect on and advance our shared mission to develop and deliver urgently needed new TB vaccines without delay. We look forward to working closely with our Spanish partners to ensure the upcoming Forum drives scientific exchange and strengthens partnerships to help make new TB vaccines a reality.”
As a country strongly committed to Global Health and Development, including longstanding partnerships across Latin America, Spain is home to world-renowned research and healthcare institutions and biopharmaceutical companies with expertise in TB and infectious diseases, vaccinology, immunology, and respiratory medicine. Its diverse scientific community is engaged in the full spectrum of TB research, making significant contributions to basic and translational research, preclinical and clinical development, and operational and implementation research. Spain is well-positioned to expand its contributions to global health and development, and to the global goal of developing and delivering new TB vaccines to end TB.
TB remains a major global health threat. We urgently need new TB vaccines to eliminate TB and reach the 2030 end TB goals. With multiple candidates in late-stage development, new TB vaccines could be available this decade. The spirit of innovation and collaboration exemplified by Spain and the European region will be critical to ensuring new TB vaccines are developed and deployed as quickly as possible.
The 8th Global Forum Organizers look forward to announcing more details about the Forum and how to participate over the coming months.
***
About the Global Forum on TB Vaccines
The Global Forum is the world’s largest gathering of TB vaccine stakeholders and allows researchers, clinicians, product developers, policymakers, civil society, and affected community groups to take stock of advances in the field, exchange perspectives on the latest research and best practices, and define priority actions aimed at accelerating the development and implementation of new vaccines against this disease. Previous Global Forums were in Geneva (2001), Tallinn (2010), Cape Town (2013), Shanghai (2015), New Delhi (2018), a virtual edition (2021), Toulouse (hosted virtually, 2022), and Rio de Janeiro (2024).
Visit www.tbvaccinesforum.org/zaragoza for information about the 8th Global Forum and to subscribe for announcements and updates.
Follow the Global Forum on LinkedIn and X to stay up to date.